LH insider transaction filings
LABCORP HOLDINGS INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-03. Screen LH transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 10 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings by 6 insiders — 10,339 shares, $3,265,700 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 4,669 shares @ $320.37 ($1,495,808) by Schechter Adam H, filed 2026-08-12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Schechter Adam H — President & CEO, Director | 1 | — | 1 leg · 4,669 sh · $1,495,808 | — |
| ANDERSON KERRII B — Director | 1 | — | 1 leg · 3,000 sh · $954,060 | — |
| Wilkinson Peter J — SVP, Chief Accounting Officer | 1 | — | 2 legs · 1,420 sh · $439,107 | 2 |
| Summy Amy B. — EVP, Chief Marketing Officer | 1 | — | 1 leg · 924 sh · $283,428 | — |
| Vaughn Bryan T — EVP and President, Diagnostics | 2 | — | 1 leg · 234 sh · $66,968 | 4 |
| Kyle Kathryn W — EVP, Chief Legal Officer | 1 | — | 1 leg · 92 sh · $26,329 | 3 |
| Caveney Brian J — EVP, Pres of BLS, CMO & CSO | 1 | — | — | 1 |
| Meltzer Jonathan C — EVP, COO | 1 | — | — | 1 |
| Oyegunwa Akinbolade — EVP, CIO & CTO | 1 | — | — | 1 |
Recent Form 4 filings — LABCORP HOLDINGS INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Vaughn Bryan T — EVP and President, Diagnostics | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Meltzer Jonathan C — EVP, COO | Grant/award (A): 900 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Oyegunwa Akinbolade — EVP, CIO & CTO | Grant/award (A): 750 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Caveney Brian J — EVP, Pres of BLS, CMO & CSO | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | ANDERSON KERRII B — Director | Sale (S): 3,000 @ $318.02 | EDGAR |
| 2026-08-12 | 4 | Schechter Adam H — President & CEO, Director | Sale (S): 4,669 @ $320.37 | EDGAR |
| 2026-08-06 | 4 | Summy Amy B. — EVP, Chief Marketing Officer | Sale (S): 924 @ $306.74 | EDGAR |
| 2026-08-05 | 4 | Wilkinson Peter J — SVP, Chief Accounting Officer | Sale (S): 82 @ $309.22 · Option exercise (M): 1,338 @ $209.25 · Sale (S): 1,338 @ $309.23 · Option exercise (M): 1,338 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Vaughn Bryan T — EVP and President, Diagnostics | Option exercise (M): 327 · Tax withholding (F): 93 @ $283.88 · Sale (S): 234 @ $286.19 · Option exercise (M): 327 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Kyle Kathryn W — EVP, Chief Legal Officer | Option exercise (M): 256 · Tax withholding (F): 73 @ $283.88 · Sale (S): 92 @ $286.19 · Option exercise (M): 256 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Kyle Kathryn W — EVP, Chief Legal Officer | Sale (S): 762 @ $263.89 | EDGAR |
| 2026-05-13 | 4 | Schechter Adam H — President & CEO, Director | Sale (S): 5,903 @ $254.50 | EDGAR |
| 2026-03-30 | 4 | Vaughn Bryan T — EVP, Diagnostics | Grant/award (A): 1,584 @ $0 · Tax withholding (F): 451 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Meltzer Jonathan C — EVP, Operations | Grant/award (A): 2,388 @ $0 · Tax withholding (F): 711 @ $268.38 · Sale (S): 839 @ $267.05 | EDGAR |
| 2026-03-30 | 4 | Kyle Kathryn W — EVP, Chief Legal Officer | Grant/award (A): 1,584 @ $0 · Tax withholding (F): 451 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Oyegunwa Akinbolade — EVP, CIO & CTO | Grant/award (A): 1,340 @ $0 · Tax withholding (F): 382 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Bailey Megan D. — EVP, Pres, Central Labs & Intl | Grant/award (A): 1,184 @ $0 · Tax withholding (F): 481 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Summy Amy B. — EVP, Chief Marketing Officer | Grant/award (A): 3,994 @ $0 · Tax withholding (F): 1,836 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Schroeder Mark S — EVP, Pres Diagnostics & COO | Grant/award (A): 9,304 @ $0 · Tax withholding (F): 4,600 @ $268.38 · Grant/award (A): 2,968 @ $0 · Tax withholding (F): 1,468 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Caveney Brian J — EVP, Pres of ED, CMO & CSO | Grant/award (A): 9,304 @ $0 · Tax withholding (F): 4,042 @ $268.38 · Grant/award (A): 1,986 @ $0 · Tax withholding (F): 863 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | van der Vaart Sandra D — EVP, Corporate Affairs | Grant/award (A): 6,382 @ $0 · Tax withholding (F): 2,722 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | Wilkinson Peter J — SVP, Chief Accounting Officer | Grant/award (A): 2,388 @ $0 · Tax withholding (F): 755 @ $268.38 · Sale (S): 1,633 @ $267.05 | EDGAR |
| 2026-03-30 | 4 | Schechter Adam H — President & CEO, Director | Grant/award (A): 58,470 @ $0 · Tax withholding (F): 26,106 @ $268.38 | EDGAR |
| 2026-03-30 | 4 | GRAHAM ANITA Z — EVP, CHRO | Grant/award (A): 6,604 @ $0 · Tax withholding (F): 2,879 @ $268.38 | EDGAR |
| 2026-03-05 | 4 | Schechter Adam H — President & CEO, Director | Sale (S): 8,705 @ $279.96 | EDGAR |
| 2026-03-03 | 4 | van der Vaart Sandra D — EVP, Corporate Affairs | Sale (S): 547.54 @ $284.91 | EDGAR |
| 2026-02-26 | 4 | Caveney Brian J — EVP, Pres of ED, CMO & CSO | Sale (S): 1,500 @ $286.31 | EDGAR |
| 2026-02-23 | 4 | Wilkinson Peter J — SVP, Chief Accounting Officer | Sale (S): 666 @ $277.94 | EDGAR |
| 2026-02-13 | 4 | Vaughn Bryan T — EVP, Diagnostics | Option exercise (M): 323 · Tax withholding (F): 93 @ $289.89 · Option exercise (M): 323 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Meltzer Jonathan C — EVP, Operations | Option exercise (M): 243 · Tax withholding (F): 70 @ $289.89 · Sale (S): 87 @ $290.42 · Option exercise (M): 243 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Kyle Kathryn W — EVP, Chief Legal Officer | Option exercise (M): 216 · Tax withholding (F): 62 @ $289.89 · Option exercise (M): 216 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Oyegunwa Akinbolade — EVP, CIO & CTO | Option exercise (M): 230 · Tax withholding (F): 68 @ $289.89 · Option exercise (M): 230 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Bailey Megan D. — EVP, Pres, Central Labs & Intl | Option exercise (M): 403 · Tax withholding (F): 138 @ $289.89 · Option exercise (M): 403 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Kliphouse Kirsten Marie — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Wang Julia Aijun — Chief Financial Officer, EVP | Option exercise (M): 860 · Tax withholding (F): 245 @ $289.89 · Option exercise (M): 860 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Summy Amy B. — EVP, Chief Marketing Officer | Option exercise (M): 230 · Tax withholding (F): 83 @ $289.89 · Option exercise (M): 230 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Schroeder Mark S — EVP, Pres Diagnostics & COO | Option exercise (M): 806 · Tax withholding (F): 259 @ $289.89 · Option exercise (M): 806 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Wengel Kathryn E — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Caveney Brian J — EVP, Pres of ED, CMO & CSO | Option exercise (M): 740 · Tax withholding (F): 211 @ $289.89 · Option exercise (M): 740 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Davis Jeffrey A. — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Rothman Paul — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Parham Richelle P — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | van der Vaart Sandra D — EVP, Corporate Affairs | Option exercise (M): 376 · Tax withholding (F): 99 @ $289.89 · Option exercise (M): 376 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Kong Garheng — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Wilkinson Peter J — SVP, Chief Accounting Officer | Option exercise (M): 536 · Tax withholding (F): 160 @ $289.89 · Option exercise (M): 160 · Tax withholding (F): 46 @ $289.89 · Option exercise (M): 536 (derivative) @ $0 · Option exercise (M): 160 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Schechter Adam H — President & CEO, Director | Sale (S): 5,273 @ $284.38 · Option exercise (M): 3,656 · Tax withholding (F): 1,521 @ $289.89 · Option exercise (M): 3,656 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | NEUPERT PETER M — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ANDERSON KERRII B — Director | Option exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | GRAHAM ANITA Z — EVP, CHRO | Option exercise (M): 356 · Tax withholding (F): 109 @ $289.89 · Option exercise (M): 356 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | GRAHAM ANITA Z — EVP, CHRO | Grant/award (A): 4,100 (derivative) @ $0 · Grant/award (A): 1,360 (derivative) @ $0 | EDGAR |
Recent 8-K events — LABCORP HOLDINGS INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →